Current Research Studies

APEC1621SC: Pediatric MATCH (Molecular Analysis for Therapy Choice)


What is the goal of the study?

The goal of this phase 2 study is to evaluate patients' overall response rate to treatment.

Who can participate in the study?

This study may be a good fit for children and young adults who: - are between the ages of 12 months to 21 years old, and - have a diagnosis of recurrent or refractory solid tumors, including non-Hodgkin lymphomas; histiocytoses (e.g. langerhans cell histiocytosis [LCH], juvenile xanthogranuloma [JXG], histiocytic sarcoma); or central nervous system (CNS) tumors.

Study Team: